The Lancet Rheumatology

1. Lancet Rheumatol5 Jul 2023

   Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level

   Cross-sectional studyGout & crystals

2. Lancet RheumatolJuly 2023

   The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial

   Secondary analysisVasculitis & PMR

3. Lancet RheumatolJuly 2023

   Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study

   Cohort studyRA

4. Lancet Rheumatol12 Jun 2023

   Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis

   Meta-analysisOsteoarthritis

5. Lancet RheumatolJune 2023

   Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

   Randomized controlled trialVasculitis & PMR

6. Lancet Rheumatol22 May 2023

   Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

   Research articleFibromyalgia & pain

7. Lancet Rheumatol8 May 2023

   Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

   Cohort studySjögren's & overlap

8. Lancet RheumatolMay 2023

   Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study

   Cohort studyLupus & APS

9. Lancet RheumatolMay 2023

   Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study

   Randomized controlled trialRA

10. Lancet Rheumatol4 Apr 2023

    Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial

    Randomized controlled trialOsteoarthritis

11. Lancet RheumatolApril 2023

    Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial

    Randomized controlled trialRA

12. Lancet Rheumatol27 Mar 2023

    Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study

    Cohort studyRA

13. Lancet Rheumatol6 Mar 2023

    Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study

    Cohort studySpondyloarthritis & PsA

14. Lancet Rheumatol6 Mar 2023

    1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial

    Randomized controlled trialVasculitis & PMR

15. Lancet Rheumatol20 Feb 2023

    Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial

    Secondary analysisVasculitis & PMR

16. Lancet Rheumatol14 Feb 2023

    Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

    Cohort studyPediatric

17. Lancet Rheumatol30 Jan 2023

    Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study

    Cohort studySpondyloarthritis & PsA

18. Lancet Rheumatol24 Jan 2023

    Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: a nested case–control study

    Case-control studyRA

19. Lancet Rheumatol24 Jan 2023

    Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

    Randomized controlled trialMyositis

20. Lancet Rheumatol23 Jan 2023

    Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study

    Cohort studyAcross diseases

21. Lancet Rheumatol10 Jan 2023

    Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study

    Cohort studyAcross diseases

22. Lancet RheumatolJanuary 2023

    Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

    Randomized controlled trialSpondyloarthritis & PsA

23. Lancet Rheumatol28 Nov 2022

    Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial

    Secondary analysisLupus & APS

24. Lancet Rheumatol16 Nov 2022

    Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

    Cohort studyAcross diseases

All 184 Briefs in ExploreShowing Briefs 161–184 of 184, newest first